UnitedHealth Group, US91324P1021

UnitedHealth Group consensus stays bullish, shares hold above 400 dollars

23.06.2026 - 22:48:23 | ad-hoc-news.de

UnitedHealth Group remains a core healthcare bellwether on the NYSE, with a clear analyst consensus and solid share price above 400 dollars amid broader S&P 500 strength.

UnitedHealth Group, US91324P1021
UnitedHealth Group, US91324P1021

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 22:46.

UnitedHealth Group (US91324P1021) continues to trade as one of the largest healthcare names on the NYSE, with the shares quoted a little above 400 dollars on Tuesday according to MarketScreener and TrendSpider. Analysts keep a distinctly positive view on the Dow Jones and S&P 500 constituent, with recent target price increases underlining the bullish consensus.

What recent analyst notes show

On June 8, JPMorgan lifted its price target on UnitedHealth Group to 466 dollars from 420 dollars while reiterating an Overweight rating, according to a MarketScreener aggregation of research updates. A week later, Leerink Partners moved its target from 400 dollars to 462 dollars and maintained an Outperform recommendation, adding another supportive signal from the sell side.

The trend of upward revisions fits a broader view of UnitedHealth as a core defensive and growth vehicle within US healthcare, often compared with peers such as Cigna and CVS Health. According to TrendSpider, 100 percent of the analysts tracked currently rate the shares a buy, signaling an unusually strong consensus at this stage of the cycle.

Consensus picture and performance

UnitedHealth shares have been trading around 406 to 408 dollars in recent sessions, with MarketScreener quoting 406.68 dollars and a day change of about 1.4 percent early this week. Capital.com cites a spot price of roughly 408.25 dollars for UNH CFDs, illustrating that the stock remains comfortably above the 400 dollar mark despite market volatility.

TrendSpider data show that UnitedHealth Group’s stock is up roughly 4.6 percent over the last 30 days, highlighting a modest but consistent upward drift. The same data set points to above average trading volume over the past month, suggesting that investor interest in the shares remains robust as the sector digests political and regulatory headlines.

Go deeper

All news and analysis on the UnitedHealth Group shares

Further background, price data and research updates on UnitedHealth Group are available in the dedicated topic section and via the company’s investor relations page.

How the money is made

UnitedHealth Group operates a diversified healthcare model built around UnitedHealthcare insurance plans and the Optum health services platform, combining coverage with data-driven clinical and pharmacy services. The group generates revenue from premiums, care delivery, pharmacy benefit management and technology-enabled services to employers, governments and individuals.

Where the stock trades today

UnitedHealth Group shares (US91324P1021) trade on the NYSE under the ticker UNH and were last quoted at around 406.68 dollars on 2026-06-23, 18:27 Eastern time according to MarketScreener. That level keeps the US-based healthcare heavyweight firmly within the Dow Jones Industrial Average and S&P 500 benchmarks.

Key data on the UnitedHealth Group shares

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • WKN: 869561
  • Ticker: UNH
  • Trading venue: NYSE
  • Price (as of 2026-06-23, 18:27): 406.68 USD
  • Market cap: 375.00 billion USD (as of 2026-06-23)
  • Sector / industry: Health Care / Managed Health Care
  • Index membership: Dow Jones Industrial Average, S&P 500, S&P 100
  • Next earnings date: 2026-07-16

More on the UnitedHealth Group shares in social media

Disclaimer: This article is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell securities. All data were obtained from sources believed to be reliable but cannot be guaranteed. Investors should conduct their own research and, where appropriate, consult a professional advisor before making investment decisions.

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69613932 | bgmi